Cargando…

Prognostic nutritional index before adjuvant chemotherapy predicts chemotherapy compliance and survival among patients with non-small-cell lung cancer

BACKGROUND: Adjuvant chemotherapy after the complete resection of non-small-cell lung cancer (NSCLC) is now the standard of care. To improve survival, it is important to identify risk factors for the continuation of adjuvant chemotherapy. In this study, we analyzed chemotherapy compliance and magnit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shimizu, Katsuhiko, Okita, Riki, Saisho, Shinsuke, Yukawa, Takuro, Maeda, Ai, Nojima, Yuji, Nakata, Masao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4603722/ https://www.ncbi.nlm.nih.gov/pubmed/26504397 http://dx.doi.org/10.2147/TCRM.S92961

Ejemplares similares

Cyclooxygenase-2 expression is a prognostic biomarker for non-small cell lung cancer patients treated with adjuvant platinum-based chemotherapy
por: Shimizu, Katsuhiko, et al.
Publicado: (2015)

Lapatinib enhances trastuzumab-mediated antibody-dependent cellular cytotoxicity via upregulation of HER2 in malignant mesothelioma cells
por: OKITA, RIKI, et al.
Publicado: (2015)

Clinical significance of dual-time-point 18F-FDG PET imaging in resectable non-small cell lung cancer
por: Shimizu, Katsuhiko, et al.
Publicado: (2015)

Difference in prognostic values of maximal standardized uptake value on fluorodeoxyglucose-positron emission tomography and cyclooxygenase-2 expression between lung adenocarcinoma and squamous cell carcinoma
por: Shimizu, Katsuhiko, et al.
Publicado: (2014)

Preoperative neutrophil/lymphocyte ratio and prognostic nutritional index predict survival in patients with non-small cell lung cancer
por: Shimizu, Katsuhiko, et al.
Publicado: (2015)

Pneumatosis intestinalis after gefitinib therapy for pulmonary adenocarcinoma: a case report
por: Maeda, Ai, et al.
Publicado: (2016)

Clinicopathological and immunohistochemical features of lung invasive mucinous adenocarcinoma based on computed tomography findings
por: Shimizu, Katsuhiko, et al.
Publicado: (2016)

Prognostic value of Cox-2 and PD-L1 expression and its relationship with tumor-infiltrating lymphocytes in resected lung adenocarcinoma
por: Shimizu, Katsuhiko, et al.
Publicado: (2017)

Comparative study of the PD-L1 expression and CD8+ tumor-infiltrating lymphocyte between surgically resected and matched re-biopsy specimens in recurrent non-small cell lung cancer
por: Shimizu, Katsuhiko, et al.
Publicado: (2019)

Clinicopathological relevance of tumor expression of NK group 2 member D ligands in resected non-small cell lung cancer
por: Okita, Riki, et al.
Publicado: (2019)

Influence of vascular endothelial growth factor single nucleotide polymorphisms on non-small cell lung cancer tumor angiogenesis
por: MAEDA, AI, et al.
Publicado: (2012)

A case report of intrapulmonary schwannoma
por: Yukawa, Takuro, et al.
Publicado: (2013)

Tofacitinib overcomes an IFNγ‐induced decrease in NK cell‐mediated cytotoxicity via the regulation of immune‐related molecules in LC‐2/ad
por: Okita, Riki, et al.
Publicado: (2021)

Membrane-bound estrogen receptor-α expression and epidermal growth factor receptor mutation are associated with a poor prognosis in lung adenocarcinoma patients
por: Shimizu, Katsuhiko, et al.
Publicado: (2012)

Contrasting Effects of the Cytotoxic Anticancer Drug Gemcitabine and the EGFR Tyrosine Kinase Inhibitor Gefitinib on NK Cell-Mediated Cytotoxicity via Regulation of NKG2D Ligand in Non-Small-Cell Lung Cancer Cells
por: Okita, Riki, et al.
Publicado: (2015)

Actual compliance to adjuvant chemotherapy in gastric cancer
por: Kim, Dong-Wook, et al.
Publicado: (2019)

Tegafur‐uracil‐induced pericardial effusion during adjuvant chemotherapy for resected lung adenocarcinoma: A case report
por: Kawamoto, Nobutaka, et al.
Publicado: (2021)

Effect of laparoscopic gastrectomy on compliance with adjuvant chemotherapy in patients with gastric cancer
por: Bao, Huizheng, et al.
Publicado: (2017)

Comparison of Compliance of Adjuvant Chemotherapy Between Laparoscopic and Open Surgery in Patients With Colon Cancer
por: Chun, Kan Ho, et al.
Publicado: (2014)

Impact of ERAS compliance on the delay between surgery and adjuvant chemotherapy in hepatobiliary and pancreatic malignancies
por: St-Amour, Pénélope, et al.
Publicado: (2020)

Adjuvant chemotherapy
por: Glimelius, B.
Publicado: (2013)

The palatability of oral nutritional supplements: before, during, and after chemotherapy
por: IJpma, Irene, et al.
Publicado: (2016)

Association between depression and anxiety status of breast cancer patients before adjuvant chemotherapy and chemotherapy‐induced adverse events
por: Lv, Dan, et al.
Publicado: (2022)

Chemotherapy is a risk factor of lymphopenia before adjuvant radiotherapy in breast cancer
por: Chen, Fang, et al.
Publicado: (2021)

Compliance and Effective Management of the Hand-Foot Syndrome in Colon Cancer Patients Receiving Capecitabine as Adjuvant Chemotherapy
por: Son, Hyun-Sook, et al.
Publicado: (2009)

The Prognostic Significance of Compliance with Postoperative Adjuvant Chemotherapy in Patients with Stage III Gastric Cancer: an Observational Study
por: Jang, Sung Ho, et al.
Publicado: (2018)

Factors related to compliance with adjuvant chemotherapy in patients with gastric cancer: A retrospective single-center study
por: Jin, Geon Yi, et al.
Publicado: (2021)

Application of PET/CT to adjuvant chemotherapy for early lung adenocarcinoma
por: Sasada, Shinsuke, et al.
Publicado: (2015)

Precision medicine for adjuvant chemotherapy of resected colorectal cancer
por: Miyamoto, Yuji, et al.
Publicado: (2020)

Comparisons of histological features among primary oral squamous cell carcinomas before and after adjuvant chemotherapy and their lymph node metastatic cancer lesions after adjuvant chemotherapy
por: Cheng, Feng-Chou, et al.
Publicado: (2022)

Adjuvant chemotherapy for colorectal cancer
por: Maughan, T S
Publicado: (2001)

Nutritional status predicts adjuvant chemotherapy outcomes for stage III colorectal cancer
por: Ihara, Keisuke, et al.
Publicado: (2019)

Preoperative Nutritional Status Contributes to the Development of Neutropenia Event in Patients With Gastric Cancer Receiving CAPEOX Adjuvant Chemotherapy
por: Xiao, Ai Tang, et al.
Publicado: (2020)

High compliance with guideline recommendations but low completion rates of adjuvant chemotherapy in resected pancreatic cancer: A cohort study
por: Weinrich, Malte, et al.
Publicado: (2018)

Randomized feasibility study of S-1 for adjuvant chemotherapy in completely resected Stage IA non–small-cell lung cancer: results of the Setouchi Lung Cancer Group Study 0701
por: Soh, Junichi, et al.
Publicado: (2016)

Prognosis and adjuvant chemotherapy for patients with positive peritoneal cytology in stage IA endometrial cancer
por: Kanno, Motoko, et al.
Publicado: (2022)

Adjuvant Chemotherapy in Node-Negative Advanced Gastric Cancer Patients
por: Su, Jian-wei, et al.
Publicado: (2022)

Promotion of the Warburg effect is associated with poor benefit from adjuvant chemotherapy in colorectal cancer
por: Kitazawa, Masashi, et al.
Publicado: (2020)

Adjuvant chemotherapy for early breast cancer.
por: Henderson, I. C.
Publicado: (1990)

Adjuvant chemotherapy in head and neck cancer.
por: Stell, P. M., et al.
Publicado: (1990)

Cannot write session to /tmp/vufind_sessions/sess_uqi0irotu4oktcs62990tb8g06